Skip To Content

ACD/Labs Blog

Joel Michalski
Se você está envolvido no Desenvolvimento de Novos Fármacos, este Webinar é para você. O desenvolvimento de processos farmacêuticos envolve grupos multidisciplinares de químicos e analistas cujo objetivo é produzir Ingrediente(s) Farmacêutico(s) Ativo(s) – IFAs de acordo com a rota mais econômica e eficiente, garantindo a segurança do produto por meio de medidas eficazes de...

Joel Michalski
Imad Haidar Ahmad and colleagues at Merck present multifactorial peak crossover (MPC)—a new technique to quickly isolate peaks of interest. Using computer-assisted chromatographic modelling, the separation landscape is mapped and conditions that change peak-elution orders are found. Peaks of interest can be quickly shifted to convenient areas of the chromatogram, dramatically reducing the time spent...

Joel Michalski
Joe DiMartino spoke with Pharmaceutical Technology about the impact COVID-19 is having on the pharmaceutical supply chain and how companies can prepare for these challenges.

Joel Michalski
The knowledge generated in metabolite identification studies can provide valuable insights for intelligent drug design, and the maximum value from these studies can be harvested only if the data are stored and easily accessible within the organization. Similarly, synthetic reactions, forced degradation/stability studies, impurity identification, structural characterization, environmental stability studies and many other activities generate...